With facilites in Northern California and in China, Astalake Biosystems is structured around development of a low-cost large-scale high-yielding botanical-based biomanufacturing system of high-value natural-chemicals, nutraceuticals, and translational medicines. A spin-off biotechnology company from researchers at Lawrence Berkeley National Laboratory (LBNL: Berkeley Lab) and the University of California Division of Agriculture and Natural Resources (UC ANR), the firm is organized around development and commercialization of emerging scientific insights that can bring environmental sustainability through new biological products or improved biological capabilities, Astalake Biosystems's novel computational biology platform, botanical biotechnology platform, and nanotechnology platform have been advancing new products. Featuring low-cost high-yield production of both traditional and advanced natural-derived metabolites based on the firm patent portfolio, Astalake Biosystems also provides expert IT consultancy and operational support to scientists in the global computational biology/bioinformatics research for high-value biochemicals, nutraceuticals, and translational medicines productions.
